OccamzRazor

OccamzRazor combines machine learning and first-in-class biological techniques to improve outcomes in drug discovery and development. Our analysis pipeline consists of two proprietary technologies, Panoramic AI and RazorBrain. Together, they are designed to extract data from unstructured text sources (publications, patient reported outcomes, etc.) and join them with structured data (genomics, proteomics, phenomics, etc.) to generate stronger drug discovery hypotheses and more valuable insights. Successful applications include data extraction and curation from biomedical text, novel target identification, and drug repurposing/repositioning.

OccamzRazor headquartered in New York, New York, United States, North America, operates in the Biotechnology, Artificial Intelligence (AI), Machine Learning, Neuroscience sector. The company focuses on Biotechnology and has secured $1.4B in funding across 112 round(s). With a team of 11-50 employees, OccamzRazor is actively contributing to advancements in Biotechnology. Their latest funding round, Grant - OccamzRazor, raised $650.0K. Discover more about their projects, partnerships, and impact on our platform.